- Home
- SNY vs CB Comparison
SNY vs CB Comparison
Compare SNY & CB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- CB
- Stock Information
- Founded
- SNY 1994
- CB 1985
- Country
- SNY France
- CB Switzerland
- Employees
- SNY N/A
- CB N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- CB Property-Casualty Insurers
- Sector
- SNY Health Care
- CB Finance
- Exchange
- SNY Nasdaq
- CB Nasdaq
- Market Cap
- SNY 120.2B
- CB 114.2B
- IPO Year
- SNY N/A
- CB 1993
- Fundamental
- Price
- SNY $47.71
- CB $273.24
- Analyst Decision
- SNY Buy
- CB Buy
- Analyst Count
- SNY 2
- CB 20
- Target Price
- SNY $57.50
- CB $289.00
- AVG Volume (30 Days)
- SNY 2.7M
- CB 1.7M
- Earning Date
- SNY 01-30-2025
- CB 01-28-2025
- Dividend Yield
- SNY 4.27%
- CB 1.33%
- EPS Growth
- SNY N/A
- CB 44.45
- EPS
- SNY 4.00
- CB 24.43
- Revenue
- SNY $54,031,898,261.00
- CB $54,697,000,000.00
- Revenue This Year
- SNY $3.18
- CB N/A
- Revenue Next Year
- SNY $6.67
- CB $6.63
- P/E Ratio
- SNY $23.72
- CB $11.18
- Revenue Growth
- SNY 6.01
- CB 13.16
- 52 Week Low
- SNY $45.22
- CB $220.21
- 52 Week High
- SNY $58.97
- CB $302.05
- Technical
- Relative Strength Index (RSI)
- SNY 45.07
- CB 36.80
- Support Level
- SNY $47.01
- CB $271.28
- Resistance Level
- SNY $49.73
- CB $277.82
- Average True Range (ATR)
- SNY 0.73
- CB 4.62
- MACD
- SNY 0.16
- CB -0.86
- Stochastic Oscillator
- SNY 48.60
- CB 11.45
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.